Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - propofol, quantity: 10 mg/ml - injection, emulsion - excipient ingredients: soya oil; egg lecithin; medium chain triglycerides; glycerol; sodium oleate; water for injections - because of the difficulty in titrating small volumes, propofol-lipuro 2% should not be used in children aged from one month to 3 years.,induction of general anaesthesia in children and adults propofol-lipuro is a short-acting intravenous anaesthetic agent suitable for induction of general anaesthesia in adults and children aged one month and older.,maintenance of general anaesthesia in children and adults propofol-lipuro is a short acting intravenous anaesthetic agent suitable for maintenance of general anaesthesia in adults and children aged 3 years and older.,propofol-lipuro 1% may also be used for maintenance of general anaesthesia in children aged from one month to 3 years for procedures not exceeding 60 minutes, unless alternative anaesthetic agents should be avoided.,propofol has no analgesic properties.,use for sedation during intensive care in adults propofol-lipuro may also be used in patients >16 years for sedation of ventilated patients receiving intensive care.,conscious sedation for surgical and diagnostic procedures propofol-lipuro may also be used for monitored conscious sedation for surgical and diagnostic procedures in,? propofol-lipuro 1%: adults and children aged one month and older. ? propofol-lipuro 2%: adults and children aged 3 years and older.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - propofol, quantity: 10 mg/ml - injection, emulsion - excipient ingredients: water for injections; glycerol; medium chain triglycerides; sodium oleate; soya oil; egg lecithin - because of the difficulty in titrating small volumes, propofol-lipuro 2% should not be used in children aged from one month to 3 years.,induction of general anaesthesia in children and adults propofol-lipuro is a short-acting intravenous anaesthetic agent suitable for induction of general anaesthesia in adults and children aged one month and older.,maintenance of general anaesthesia in children and adults propofol-lipuro is a short acting intravenous anaesthetic agent suitable for maintenance of general anaesthesia in adults and children aged 3 years and older.,propofol-lipuro 1% may also be used for maintenance of general anaesthesia in children aged from one month to 3 years for procedures not exceeding 60 minutes, unless alternative anaesthetic agents should be avoided.,propofol has no analgesic properties.,use for sedation during intensive care in adults propofol-lipuro may also be used in patients >16 years for sedation of ventilated patients receiving intensive care.,conscious sedation for surgical and diagnostic procedures propofol-lipuro may also be used for monitored conscious sedation for surgical and diagnostic procedures in,? propofol-lipuro 1%: adults and children aged one month and older. ? propofol-lipuro 2%: adults and children aged 3 years and older.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - rocuronium bromide, quantity: 100 mg - injection, solution - excipient ingredients: sodium acetate; sodium chloride; glacial acetic acid; sodium hydroxide; water for injections - adjunct to general anaesthesia to facilitate endotracheal intubation during routine induction, to provide muscle relaxation and to facilitate mechanical ventilation in adults, children and infants over 1 month of age. adjunct to general anaesthesia to facilitate endotracheal intubation during rapid sequence induction when suxamethonium is contraindicated, however, this has not been studied in infants and children. adjunct in the intensive care unit (icu) to facilitate mechanical ventilation.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - rocuronium bromide, quantity: 50 mg - injection, solution - excipient ingredients: sodium acetate; sodium chloride; glacial acetic acid; sodium hydroxide; water for injections - adjunct to general anaesthesia to facilitate endotracheal intubation during routine induction, to provide muscle relaxation and to facilitate mechanical ventilation in adults, children and infants over 1 month of age. adjunct to general anaesthesia to facilitate endotracheal intubation during rapid sequence induction when suxamethonium is contraindicated, however, this has not been studied in infants and children. adjunct in the intensive care unit (icu) to facilitate mechanical ventilation.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - propofol, quantity: 1000 mg - injection, emulsion - excipient ingredients: water for injections; glycerol; soya oil; medium chain triglycerides; sodium oleate; egg lecithin; sodium hydroxide - short acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and children aged three years and older. provive mct-lct 1% has no analgesic properties. although the safety and efficacy of propofol in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. provive mct-lct 1% may also be used in adults for sedation of ventilated patients receiving intensive care. provive mct-lct 1% may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - propofol, quantity: 500 mg - injection, emulsion - excipient ingredients: glycerol; soya oil; sodium hydroxide; medium chain triglycerides; water for injections; egg lecithin; sodium oleate - short acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and children aged three years and older. provive mct-lct 1% has no analgesic properties. although the safety and efficacy of propofol in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. provive mct-lct 1% may also be used in adults for sedation of ventilated patients receiving intensive care. provive mct-lct 1% may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - propofol, quantity: 200 mg - injection, emulsion - excipient ingredients: medium chain triglycerides; sodium oleate; glycerol; sodium hydroxide; water for injections; egg lecithin; soya oil - short acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and children aged three years and older. provive mct-lct 1% has no analgesic properties. although the safety and efficacy of propofol in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. provive mct-lct 1% may also be used in adults for sedation of ventilated patients receiving intensive care. provive mct-lct 1% may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - propofol, quantity: 1000 mg - injection, emulsion - excipient ingredients: soya oil; glycerol; egg lecithin; sodium oleate; sodium hydroxide; water for injections - short acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and children aged three years and older. anesia 1% has no analgesic properties. although the safety and efficacy of propofol in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. anesia 1% may also be used in adults for sedation of ventilated patients receiving intensive care. anesia1% may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - propofol, quantity: 500 mg - injection, emulsion - excipient ingredients: soya oil; glycerol; egg lecithin; sodium oleate; sodium hydroxide; water for injections - short acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and children aged three years and older. anesia1% has no analgesic properties. although the safety and efficacy of propofol in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. anesia 1% may also be used in adults for sedation of ventilated patients receiving intensive care. anesia 1% may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - propofol, quantity: 200 mg - injection, emulsion - excipient ingredients: sodium oleate; glycerol; egg lecithin; sodium hydroxide; water for injections; soya oil - short acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and children aged three years and older. anesia 1% has no analgesic properties. although the safety and efficacy of propofol in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. anesia 1% may also be used in adults for sedation of ventilated patients receiving intensive care. anesia 1% may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.